Bharat Biotech announces commencement of Phase III trials of COVAXIN

Category : Health & Medicine | Sub Category : Medicine Posted on 2020-11-16 15:29:39


Bharat Biotech announces commencement of Phase III trials of COVAXIN

Bharat Biotech announces commencement of Phase III trials of COVAXIN. Phase III trials will involve 26,000 volunteers across India, conducted in partnership with ICMR. It is the largest clinical trial conducted for a COViD19vaccine in India. 

Leave a Comment: